Tooth Margaret

Tooth Margaret, CEO of Trupanion (TRUP), has filed 54 Form 4 transactions over the past year, with a pronounced sell-side bias. Her total open-market sales reached $1,484,537.55, while she recorded zero open-market purchases during the period. The most recent activity, clustered around May 25, 2026, includes a $10,733.26 open-market sale, accompanied by option exercises (coded M) and shares withheld for tax obligations (coded F). These tax-withholding events, which totaled roughly $70,797.58 on May 22, 2026, are automatic and not discretionary, but they underscore the mechanical nature of much of her trading. The pattern is consistent across the filing history. In December 2025, Margaret executed two open-market sales on the same day—$60,844.75 and $303,004.80—alongside an option exercise valued at $71,440. Earlier in February 2026, she received a grant (coded A) and subsequently saw a series of F-code tax withholdings, ranging from $2,498.72 to $46,362.12, tied to vesting schedules. Notably, all 54 transactions involve TRUP exclusively, and none reflect a purchase (code P) or a sale back to the issuer (code D). The absence of any buy-side activity, combined with recurring sales tied to option exercises, suggests a consistent disposition of equity rather than accumulation. The most recent three trades—one sale and two option exercises—occurred on May 25, 2026, with the sale valued at $10,733.26. This follows a pattern where sales are often paired with option exercises, indicating that Margaret is converting vested options into cash, while the F-code withholdings cover tax liabilities. Over the entire period, her total acquired value is zero, meaning all shares came from exercises or grants, not open-market purchases. The data points to a CEO steadily monetizing equity compensation, with no recent indication of a shift toward buying.